{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:10:02Z","timestamp":1790554202688,"version":"4.1.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u2014AES 2013","doi-asserted-by":"publisher","award":["\u00a0"],"award-info":[{"award-number":["\u00a0"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","award":["\u00a0"],"award-info":[{"award-number":["\u00a0"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The stability of molecular T2\/non-T2 phenotypes remains uncertain. The objectives of this study were to assess the stability of these phenotypes and the correlation between serum periostin and asthma T2 phenotypes and endotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Demographics, clinical data, and blood samples were collected. Patients diagnosed with moderate-to-severe asthma were classified into T2 or non-T2 according to previously defined thresholds of blood eosinophilia and serum total IgE levels. Asthma endotype was also determined. After at least 1 year of follow-up, the stability of T2 phenotypes and endotypes was assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 53 patients (72% women), mean age 47 years (range 16\u201377), were included. In the initial and second evaluations, the T2 phenotype was found in 41.5% and 43.4% of patients and the non-T2 phenotype was found in 58.4% and 56.7%, respectively. The mean [standard deviation (SD), range] serum periostin level was 52.7 (26.2, 22.6\u2013129.7) ng\/mL in patients with T2 phenotype, and 39.3 (25.6, 7.7\u2013104.) ng\/mL in non-T2 patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.063). Periostin levels correlated to endotypes (<jats:italic>P<\/jats:italic>\u2009=\u20090.001): 45.7 (27.9) ng\/mL in allergic asthma (<jats:italic>n<\/jats:italic>\u2009=\u200916 patients), 64.7 (24.9) in aspirin-exacerbated respiratory disease (<jats:italic>n<\/jats:italic>\u2009=\u200914), 59.0 (27.6) ng\/mL in late-onset eosinophilic asthma (<jats:italic>n<\/jats:italic>\u2009=\u20094), and 28.3 (13.3) ng\/mL in non-eosinophilic asthma (<jats:italic>n<\/jats:italic>\u2009=\u200918).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>T2 and non-T2 asthma phenotypes assessed by accessible methods in daily practice are stable over time yet widely heterogeneous. Serum periostin does not discriminate between T2 and non-T2 phenotypes. Nevertheless, its correlation to asthma endotypes may contribute to guide therapies targeting T2 cytokines in a more personalized approach.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2023.1205115","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T12:07:35Z","timestamp":1694174855000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping"],"prefix":"10.3389","volume":"4","author":[{"given":"Irina","family":"Bobolea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Guill\u00e9n-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"De las Cuevas-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Blanco","family":"Garc\u00eda-Granero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Loli-Ausejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Melero-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1164\/rccm.201504-0763PP","article-title":"Evolving concepts of asthma","volume":"192","author":"Gauthier","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1513\/AnnalsATS.201403-097AW","article-title":"Type-2 innate lymphoid cells in asthma and allergy","volume":"11","author":"McKenzie","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1084\/jem.20052448","article-title":"Type 2 immunity is controlled by IL-4\/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system","volume":"203","author":"Voehringer","year":"2006","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/ACI.0000000000000090","article-title":"Type-2 innate lymphoid cells in human allergic disease","volume":"14","author":"Barlow","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Me"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJMe1108666","article-title":"Asthma phenotypes and interleukin-13\u2014moving closer to personalized medicine","volume":"365","author":"Kraft","year":"2011","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinopils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"B10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2500\/aap.2016.37.3945","article-title":"Association of airway wall thickness with serum periostin in steroid-naive asthma","volume":"37","author":"Hoshino","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/all.12580","article-title":"Sputum periostin in patients with different severe asthma phenotypes","volume":"70","author":"Bobolea","year":"2015","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/COPD.S153694","article-title":"Mixed Th2 and non-Th2 inflammatory pattern in the asthma COPD overlap: a network approach","volume":"13","author":"P\u00e9rez de Llano","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","article-title":"Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome","volume":"127","author":"L\u00f6tvall","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B15","year":""},{"key":"B16","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/cea.12345","article-title":"Full blood count parameters for the detection of asthma inflammatory phenotypes","volume":"44","author":"Zhang","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/thoraxjnl-2011-201064","article-title":"Stability of inflammatory phenotypes in asthma","volume":"67","author":"Green","year":"2012","journal-title":"Thorax"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jaci.2010.02.005","article-title":"Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: a prospective study using multiple samples","volume":"125","author":"Al-Samri","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/thoraxjnl-2011-201064","article-title":"Sputum inflammatory phenotypes are not stable in children with asthma","volume":"67","author":"Fleming","year":"2012","journal-title":"Thorax"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/all.12445","article-title":"Stability of phenotypes defined by physiological variables and biomarkers in adult patients with asthma","volume":"69","author":"Kupczyk","year":"2014","journal-title":"Allergy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.anai.2014.06.014","article-title":"Association of serum periostin with aspirin-exacerbated respiratory disease","volume":"113","author":"Kim","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1164\/ajrccm.153.1.8542168","article-title":"Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects","volume":"153","author":"Nasser","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/ajrccm.156.5.9702072","article-title":"Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways","volume":"156","author":"Sousa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Eng J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Res-5-0010 study group. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MCP.0000000000000231","article-title":"Role of T2 inflammation biomarkers in severe asthma","volume":"22","author":"Parulekar","year":"2016","journal-title":"Curr Opin Pulm Med"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1205115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T12:07:38Z","timestamp":1694174858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1205115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":28,"alternative-id":["10.3389\/falgy.2023.1205115"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2023.1205115","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"article-number":"1205115"}}